The Mechanism of Dynamic Interaction between Doxorubicin and Calf Thymus DNA at the Single-Molecule Level Based on Confocal Raman Spectroscopy

被引:17
作者
Zhang, Ruihong [1 ]
Zhu, Jie [1 ]
Sun, Dan [1 ]
Li, Jie [1 ]
Yao, Lina [1 ]
Meng, Shuangshuang [1 ]
Li, Yan [2 ]
Dang, Yang [1 ]
Wang, Kaige [1 ]
机构
[1] Northwest Univ, Inst Photon & Photon Technol, State Key Lab Cultivat Base Photoelect Technol &, Natl Ctr Int Res Photoelect Technol & Nano Funct, Xian 710069, Peoples R China
[2] Xian Shiyou Univ, Sch Sci, Xian 710069, Peoples R China
关键词
doxorubicin; calf thymus DNA; binding site; dynamic process; Confocal Raman spectroscopy; RESONANCE RAMAN; CANCER-CELLS; RESISTANCE; COMPLEX; SERS;
D O I
10.3390/mi13060940
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
It is of great fundamental significance and practical application to understand the binding sites and dynamic process of the interaction between doxorubicin (DOX) and DNA molecules. Based on the Confocal Raman spectroscopy, the interaction between DOX and calf thymus DNA has been systemically investigated, and some meaningful findings have been found. DOX molecules can not only interact with all four bases of DNA molecules, i.e., adenine, thymine, cytosine, guanine, and phosphate, but also affect the DNA conformation. Meanwhile, the binding site of DOX and its derivatives such as daunorubicin and epirubicin is certain. Furthermore, the interaction between DOX and DNA molecules is a dynamic process since the intensities of each characteristic peaks of the base, e.g., adenine, cytosine, and phosphate, are all regularly changed with the interaction time. Finally, a dynamic mechanism model of the interaction between DOX and DNA molecules is proposed; that is, there are two kinds of interaction between DOX and DNA molecules: DOX-DNA acts to form a complex, and DOX-DOX acts to form a multimer. The two effects are competitive, as the former compresses DNA molecules, and the latter decompresses these DNA molecules. This work is helpful for accurately understanding and developing new drugs and pathways to improve and treat DOX-induced cytotoxicity and cardiotoxicity.
引用
收藏
页数:15
相关论文
共 41 条
[1]   CLINICALLY USEFUL DOXORUBICIN ANALOGS [J].
ARCAMONE, F .
CANCER TREATMENT REVIEWS, 1987, 14 (3-4) :159-161
[2]   Correlation of in Situ Oxazolidine Formation with Highly Synergistic Cytotoxicity and DNA Cross-Linking in Cancer Cells from Combinations of Doxorubicin and Formaldehyde [J].
Barthel, Benjamin L. ;
Mooz, Erin L. ;
Wiener, Laura Elizabeth ;
Koch, Gary G. ;
Koch, Tad H. .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (05) :2205-2221
[3]   Comparative FT SERS, resonance Raman and SERRS studies of doxorubicin and its complex with DNA [J].
Beljebbar, A ;
Sockalingum, GD ;
Angiboust, JF ;
Manfait, M .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 1995, 51 (12) :2083-2090
[4]   CHARACTERIZATION OF DNA STRUCTURES BY RAMAN-SPECTROSCOPY - HIGH-SALT AND LOW-SALT FORMS OF DOUBLE HELICAL POLY(DG-DC) IN H2O AND D2O SOLUTIONS AND APPLICATION TO B-DNA, Z-DNA AND A-DNA [J].
BENEVIDES, JM ;
THOMAS, GJ .
NUCLEIC ACIDS RESEARCH, 1983, 11 (16) :5747-5761
[5]   Investigation of poly(CTAB-MWCNTs) composite based electrochemical DNA biosensor and interaction study with anticancer drug Irinotecan [J].
Bolat, Gulcin .
MICROCHEMICAL JOURNAL, 2020, 159
[7]   Novel Surface-Enhanced Raman Spectroscopy Techniques for DNA, Protein and Drug Detection [J].
Chen, Chuanpin ;
Liu, Wenfang ;
Tian, Sanping ;
Hong, Tingting .
SENSORS, 2019, 19 (07)
[8]  
Chen N.-T., 2012, PLOS ONE, V7, P1
[9]   A couple of antitumor Pd(II) complexes make DNA-refolding and HSA-unfolding: Experimental and docking studies [J].
Dustkami, Mahin ;
Mansouri-Torshizi, Hassan ;
Abdi, Khatereh ;
Dehghanian, Effat ;
Saeidifar, Maryam ;
Mohammadi, Fatemeh .
JOURNAL OF MOLECULAR LIQUIDS, 2022, 349
[10]   Prediction of broad spectrum resistance of tumors towards anticancer drugs [J].
Efferth, Thomas ;
Konkimalla, V. Badireenath ;
Wang, Yi-Fen ;
Sauerbrey, Axel ;
Meinhardt, Silke ;
Zintl, Felix ;
Mattern, Juegen ;
Volm, Manfred .
CLINICAL CANCER RESEARCH, 2008, 14 (08) :2405-2412